Showing results (941-950 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|November 21, 2025
Comparison of Efficacy and Safety Profiles Between Omadacycline and Moxifloxacin in Elderly Patients with Community-Acquired Pneumonia: A Randomized, Controlled TrialMuming Yu, Xiaorong Wang, Sitong Wu, et al.
Clinical Pharmacology in Drug Development|January 16, 2026
Pharmacokinetics and Safety of Single-Dose Apraglutide in Individuals with Normal and Impaired Hepatic Function: A Phase 1, Open-Label TrialGerard Greig, Justin Hay, Patricia Valencia, et al.
Clinical Pharmacology in Drug Development|June 26, 2025
Pharmacokinetic and Bioequivalence Evaluation of Ulipristal Acetate in Healthy Chinese Subjects in the Fasting and Postprandial ConditionsLing He, Weiyong Li, Yuxia Lv
Clinical Pharmacology in Drug Development|June 26, 2025
Two Phase I, Randomized, Open-Label, Multiple-Dose, Crossover Studies Investigating the Systemic Bioavailability of Topical Diclofenac Diethylamine Gels Compared With Oral Diclofenac TabletsGrit Andersen, Frédérique Bariguian Revel, Marianna Armogida
Clinical Pharmacology in Drug Development|June 24, 2025
Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early-Phase Clinical Study ParticipantsAndrea Francesco Daniele Di Stefano, Milko Massimiliano Radicioni, Gerhard Garhöfer, et al.
Clinical Pharmacology in Drug Development|June 24, 2025
Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label StudyAmita Datta-Mannan, Boris Czeskis, Elaine Shanks, et al.
Clinical Pharmacology in Drug Development|July 2, 2025
Bioequivalence and Pharmacokinetics of Ibuprofen Extended-Release Capsules in Healthy Chinese Volunteers Under Fasting and Postprandial ConditionsMingqi Chen, Weixiong Liu, Yiyun Wang, et al.
Clinical Pharmacology in Drug Development|September 19, 2025
A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG-055009, a novel thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH), in healthy participantsHakim Charfi, Benedetta Massetto, Megan Fitzgerald, et al.
Clinical Pharmacology in Drug Development|May 27, 2025
A Randomized Thorough QT Trial Using Concentration-QT Analysis to Evaluate the Effects of Centanafadine on Cardiac RepolarizationOsman S Turkoglu, Xiaofeng Wang, Jennifer Repella-Gordon, et al.
Clinical Pharmacology in Drug Development|July 11, 2025
Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long-Acting Intramuscular InjectionsKelong Han, Ronald D D'Amico, William R Spreen, et al.
Pageof 136